Form 8-K HAEMONETICS CORP For: Nov 03

Go back to Form 8-K HAEMONETICS CORP For: Nov 03

Haemonetics Corp. (HAE) Tops Q2 EPS by 1c

November 3, 2014 6:15 AM EST

Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.

... More